Downregulated expression of hepatomaderived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial- mesenchymal transition and MMP2, MMP9

作者：Yang, Feilong; Yu, Nengwang; Wang, Hui; Zhang, Cong; Zhang, Zhao; Li, Yanxiang; Li, Dawei^*; Yan, Lei; Liu, Hainan; Xu, Zhonghua

来源：PLos One, 2018, 13(1): e0190725.

DOI：10.1371/journal.pone.0190725

• PROGNOSTIC-FACTOR
• MATRIX METALLOPROTEINASES
• BREAST-CANCER
• HDGF

Hepatoma-derived growth factor (HDGF) is commonly over-expressed and plays critical roles in the development and progression in a variety of cancers. It has previously been shown that HDGF is overregulated in prostate cancer cells compared to normal prostate cells, which is correlated with cellular migration and invasion of prostate cancer. Here, the molecular mechanisms of HDGF in prostate cancer is investigated. It is shown that HDGF knockdown reduces prostate cancer cellular migration and invasion in both androgen-sensitive LNCaP cells and androgen-insensitive DU145 and PC3 cells. Furthermore, Western blot analysis reveals that HDGF knockdown inhibits epithelial-mesenchymal transition (EMT) of prostate cancer cells by upregulation of protein E-cadherin and downregulation of proteins N-cadherin, Vimentin, Snail and Slug. In addition, mechanistic studies reveal that proteins MMP2 and MMP9 are down-regulated. In conclusion, our data suggested that HDGF knockdown inhibits cellular migration and invasion in vitro of prostate cancer via modulating epithelial-mesenchymal transition (EMT) signaling pathway, as well as MMP2 and MMP9 signaling pathway. These results supported that HDGF is a relevant protein in the progression of prostate cancer and may serve as a potentially therapeutic target for prostate cancer as well as its downstream targets.

• 出版日期2018-1-4
• 单位山东大学